Search research articles
Contact Us
Filters
Showing results (1-10 of 264) with videos related to
Page
of 27
Sort By:
Current Medicinal Chemistry
|
February 18, 2010
Recent advances on platensimycin: a potential antimicrobial agent
Xiaoyun Lu, Qidong You
Oncology Letters
|
December 15, 2018
Expression of miR-204 in pediatric retinoblastoma and its effects on proliferation and apoptosis of cancer cells
Jian Ding, Xiaoyun Lu
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics
|
November 1, 2022
[Genetic diagnosis of a child with Café-au-lait macules and juvenile xanthogranuloma]
Xiaoyun Lu, Fengli Xiao
Trends in Pharmacological Sciences
|
October 22, 2025
WEE-family kinases in cancer: synthetic lethal interactions and drug discovery
Chaofan Wang, Xiaoyun Lu
Journal of Medicinal Chemistry
|
February 7, 2014
Novel anaplastic lymphoma kinase inhibitors targeting clinically acquired resistance
Xiaoyun Lu, Ke Ding
Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology
|
June 26, 2020
Teaching now, facing the future
Xiaoyun Lu, Yan Ding
Journal of Medicinal Chemistry
|
June 1, 2023
Targeting MET: Discovery of Small Molecule Inhibitors as Non-Small Cell Lung Cancer Therapy
Chaofan Wang, Xiaoyun Lu
Pharmaceutical Science Advances
|
June 30, 2026
Recent advances in HER2-targeted inhibitors for cancer therapy
Wenjian Zhu, Xiaoyun Lu
Acta Pharmaceutica Sinica. B
|
February 7, 2024
Selective type II TRK inhibitors overcome xDFG mutation mediated acquired resistance to the second-generation inhibitors selitrectinib and repotrectinib
Shuang Xiang, Xiaoyun Lu
Expert Opinion on Therapeutic Patents
|
June 10, 2011
Enoyl acyl carrier protein reductase inhibitors: a patent review (2006 - 2010)
Xiaoyun Lu, Kun Huang, Qidong You
Page
of 27
Search research articles
Search
Showing results (1-10 of 264) with videos related to
Sort By:
Page
of 27
Current Medicinal Chemistry
|
February 18, 2010
Recent advances on platensimycin: a potential antimicrobial agent
Xiaoyun Lu, Qidong You
Oncology Letters
|
December 15, 2018
Expression of miR-204 in pediatric retinoblastoma and its effects on proliferation and apoptosis of cancer cells
Jian Ding, Xiaoyun Lu
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics
|
November 1, 2022
[Genetic diagnosis of a child with Café-au-lait macules and juvenile xanthogranuloma]
Xiaoyun Lu, Fengli Xiao
Trends in Pharmacological Sciences
|
October 22, 2025
WEE-family kinases in cancer: synthetic lethal interactions and drug discovery
Chaofan Wang, Xiaoyun Lu
Journal of Medicinal Chemistry
|
February 7, 2014
Novel anaplastic lymphoma kinase inhibitors targeting clinically acquired resistance
Xiaoyun Lu, Ke Ding
Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology
|
June 26, 2020
Teaching now, facing the future
Xiaoyun Lu, Yan Ding
Journal of Medicinal Chemistry
|
June 1, 2023
Targeting MET: Discovery of Small Molecule Inhibitors as Non-Small Cell Lung Cancer Therapy
Chaofan Wang, Xiaoyun Lu
Pharmaceutical Science Advances
|
June 30, 2026
Recent advances in HER2-targeted inhibitors for cancer therapy
Wenjian Zhu, Xiaoyun Lu
Acta Pharmaceutica Sinica. B
|
February 7, 2024
Selective type II TRK inhibitors overcome xDFG mutation mediated acquired resistance to the second-generation inhibitors selitrectinib and repotrectinib
Shuang Xiang, Xiaoyun Lu
Expert Opinion on Therapeutic Patents
|
June 10, 2011
Enoyl acyl carrier protein reductase inhibitors: a patent review (2006 - 2010)
Xiaoyun Lu, Kun Huang, Qidong You
Page
of 27